Abstract
Wilson disease (WD), a copper metabolism disorder caused by mutations in ATP7B, manifests heterogeneous clinical features. Interestingly, in a fraction of clinically diagnosed WD patients, mutations in ATP7B appears to be missing. In this review we discuss the plausible explanations of this missing heritability and propose a workflow that can identify the hidden mutations. Mutation analyses of WD generally includes targeted sequencing of ATP7B exons, exon–intron boundaries, and rarely, the proximal promoter region. We propose that variants in the distal cis-regulatory elements and/or deep intronic variants that impact splicing might well represent the hidden mutations. Heterozygous del/ins that remain refractory to conventional PCR-sequencing method may also represent such mutations. In this review, we also hypothesize that mutations in the key copper metabolism genes, like, ATOX1, COMMD1, and SLC31A1, could possibly lead to a WD-like phenotype. In fact, WD does present overlapping symptoms with other rare genetic disorders; hence, the possibility of a misdiagnosis and thus adding to missing heritability cannot be excluded. In this regard, it seems that whole-genome analysis will provide a comprehensive and rapid molecular diagnosis of WD. However, considering the associated cost for such a strategy, we propose an alternative customized screening schema of WD which include targeted sequencing of ATP7B locus as well as other key copper metabolism genes. Success of such a schema has been tested in a pilot study.
Similar content being viewed by others
References
Acevedo KM, Hung YH, Dalziel AH, Li QX, Laughton K, Wikhe K, Rembach A, Roberts B, Masters CL, Bush AI, Camakaris J (2011) Copper promotes the trafficking of the amyloid precursor protein. J Biol Chem 286:8252–8262
Al Jumah M, Majumdar R, Al Rajeh S, Awada A, Al Zaben A, Al Traif I, Al Jumah AR, Rehana Z (2004) A clinical and genetic study of 56 Saudi Wilson disease patients: identification of Saudi-specific mutations. Eur J Neurol 11:121–124
Antos A, Litwin T, Skowronska M, Kurkowska-Jastrzebska I, Czlonkowska A (2020) Pitfalls in diagnosing Wilson’s Disease by genetic testing alone: the case of a 47-year-old woman with two pathogenic variants of the ATP7B gene. Neurol Neurochir Pol 54:478–480
Anwarullah A, Paramasivam N, Abbasi R, Khan K, Sultan A, Schlesner M, von Engelhardt J, Ahmad N, Aslam M (2017) A report of whole-genome sequencing in neurologic Wilson’s disease. Neurol India 65:629–631
Bandmann O, Weiss KH, Kaler SG (2015) Wilson’s disease and other neurological copper disorders. Lancet Neurol 14:103–113
Bansagi B, Lewis-Smith D, Pal E, Duff J, Griffin H, Pyle A, Muller JS, Rudas G, Aranyi Z, Lochmuller H, Chinnery PF, Horvath R (2016) Phenotypic convergence of Menkes and Wilson disease. Neurology Genetics 2:e119
Blaby-Haas CE, Merchant SS (2014) Lysosome-related organelles as mediators of metal homeostasis. J Biol Chem 289:28129–28136
Boga S, Jain D, Schilsky ML (2015) Presentation of Progressive familial intrahepatic cholestasis type 3 mimicking Wilson disease: molecular genetic diagnosis and response to treatment. Pediatr Gastroenterol Hepatol Nutr 18:202–208
Bost M, Piguet-Lacroix G, Parant F, Wilson CM (2012) Molecular analysis of Wilson patients: direct sequencing and MLPA analysis in the ATP7B gene and Atox1 and COMMD1 gene analysis. J Trace Elem Med Biol 26:97–101
Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW (1993) The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 5:327–337
Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, Nagle J, Polymeropoulos MH, Sturley SL, Ioannou YA, Higgins ME, Comly M, Cooney A, Brown A, Kaneski CR, Blanchette-Mackie EJ, Dwyer NK, Neufeld EB, Chang TY, Liscum L, Strauss JF 3rd, Ohno K, Zeigler M, Carmi R, Sokol J, Markie D, O’Neill RR, van Diggelen OP, Elleder M, Patterson MC, Brady RO, Vanier MT, Pentchev PG, Tagle DA (1997) Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277:228–231
Chen HI, Jagadeesh KA, Birgmeier J, Wenger AM, Guturu H, Schelley S, Bernstein JA, Bejerano G (2018) An MTF1 binding site disrupted by a homozygous variant in the promoter of ATP7B likely causes Wilson Disease. Eur J Hum Genet 26:1810–1818
Cheng Y, Liang H, Cai NL, Guo L, Huang YG, Song YZ (2017) Clinical features and MYO5B mutations of a family affected by microvillus inclusion disease. Zhongguo dang dai er ke za zhi = Chin J Contemp Pediatr 19:968–974
Choi EK, Nguyen TT, Gupta N, Iwase S, Seo YA (2018) Functional analysis of SLC39A8 mutations and their implications for manganese deficiency and mitochondrial disorders. Sci Rep 8:3163
Chuang LM, Tai TY, Wang TR, Chang YC, Chen KH, Lin RS, Lin BJ (1991) Esterase D and retinoblastoma gene loci are tightly linked to Wilson’s disease in Chinese pedigrees from Taiwan. Hum Genet 87:465–468
Coffey AJ, Durkie M, Hague S, McLay K, Emmerson J, Lo C, Klaffke S, Joyce CJ, Dhawan A, Hadzic N, Mieli-Vergani G, Kirk R, Elizabeth Allen K, Nicholl D, Wong S, Griffiths W, Smithson S, Giffin N, Taha A, Connolly S, Gillett GT, Tanner S, Bonham J, Sharrack B, Palotie A, Rattray M, Dalton A, Bandmann O (2013) A genetic study of Wilson’s disease in the United Kingdom. Brain 136:1476–1487
Collins CJ, Yi F, Dayuha R, Duong P, Horslen S, Camarata M, Coskun AK, Houwen RHJ, Pop TL, Zoller H, Yoo HW, Jung SW, Weiss KH, Schilsky ML, Ferenci P, Hahn S (2021) Direct measurement of ATP7B peptides is highly effective in the diagnosis of Wilson disease. Gastroenterology 160(7):2367–2382
Consortium EP (2004) The ENCODE (ENCyclopedia Of DNA elements) project. Science 306:636–640
Costantino L, Rusconi D, Solda G, Seia M, Paracchini V, Porcaro L, Asselta R, Colombo C, Duga S (2013) Fine characterization of the recurrent c.1584+18672A>G deep-intronic mutation in the cystic fibrosis transmembrane conductance regulator gene. Am J Respir Cell Mol Biol 48:619–625
Cullen LM, Prat L, Cox DW (2003) Genetic variation in the promoter and 5′ UTR of the copper transporter, ATP7B, in patients with Wilson disease. Clin Genet 64:429–432
Czlonkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, Rybakowski JK, Weiss KH, Schilsky ML (2018) Wilson Disease. Nat Rev Dis Primers 4:21
Das SK, Ray K (2006) Wilson’s disease: an update. Nat Clin Pract Neurol 2:482–493
Das S, Maji S, Ruturaj Bhattacharya I, Saha T, Naskar N, Gupta A (2020) Retromer retrieves the Wilson disease protein ATP7B from endolysosomes in a copper-dependent manner. J Cell Sci 133(24):jcs246819
Dobkin C, Pergolizzi RG, Bahre P, Bank A (1983) Abnormal splice in a mutant human beta-globin gene not at the site of a mutation. Proc Natl Acad Sci USA 80:1184–1188
Farooq M, Troelsen JT, Boyd M, Eiberg H, Hansen L, Hussain MS, Rehman S, Azhar A, Ali A, Bakhtiar SM, Tommerup N, Baig SM, Kjaer KW (2010) Preaxial polydactyly/triphalangeal thumb is associated with changed transcription factor-binding affinity in a family with a novel point mutation in the long-range cis-regulatory element ZRS. Eur J Hum Genet 18:733–736
Folhoffer A, Ferenci P, Csak T, Horvath A, Hegedus D, Firneisz G, Osztovits J, Kosa JP, Willheim-Polli C, Szonyi L, Abonyi M, Lakatos PL, Szalay F (2007) Novel mutations of the ATP7B gene among 109 Hungarian patients with Wilson’s disease. Eur J Gastroenterol Hepatol 19:105–111
Forman OP, Boursnell ME, Dunmore BJ, Stendall N, van den Sluis B, Fretwell N, Jones C, Wijmenga C, Rothuizen J, van Oost BA, Holmes NG, Binns MM, Jones P (2005) Characterization of the COMMD1 (MURR1) mutation causing copper toxicosis in Bedlington terriers. Anim Genet 36:497–501
Fu X, Rinaldo P, Hahn SH, Kodama H, Packman S (2003) Mutation analysis of copper transporter genes in patients with ethylmalonic encephalopathy, mitochondriopathies and copper deficiency phenotypes. J Inherit Metab Dis 26:55–66
Gomes A, Dedoussis GV (2016) Geographic distribution of ATP7B mutations in Wilson disease. Ann Hum Biol 43:1–8
Guo Y, Smith K, Lee J, Thiele DJ, Petris MJ (2004) Identification of methionine-rich clusters that regulate copper-stimulated endocytosis of the human Ctr1 copper transporter. J Biol Chem 279:17428–17433
Gupta A, Lutsenko S (2009) Human copper transporters: mechanism, role in human diseases and therapeutic potential. Future Med Chem 1:1125–1142
Gupta A, Lutsenko S (2012) Evolution of copper transporting ATPases in eukaryotic organisms. Curr Genomics 13:124–133
Gupta A, Aikath D, Neogi R, Datta S, Basu K, Maity B, Trivedi R, Ray J, Das SK, Gangopadhyay PK, Ray K (2005) Molecular pathogenesis of Wilson disease: haplotype analysis, detection of prevalent mutations and genotype-phenotype correlation in Indian patients. Hum Genet 118:49–57
Gupta A, Schell MJ, Bhattacharjee A, Lutsenko S, Hubbard AL (2016) Myosin Vb mediates Cu+ export in polarized hepatocytes. J Cell Sci 129:1179–1189
Harada M, Kawaguchi T, Kumemura H, Terada K, Ninomiya H, Taniguchi E, Hanada S, Baba S, Maeyama M, Koga H, Ueno T, Furuta K, Suganuma T, Sugiyama T, Sata M (2005) The Wilson disease protein ATP7B resides in the late endosomes with Rab7 and the Niemann-Pick C1 protein. Am J Pathol 166:499–510
Hermann W (2019) Classification and differential diagnosis of Wilson’s disease. Ann Transl Med 7:S63
Hogarth P (2015) Neurodegeneration with brain iron accumulation: diagnosis and management. J Mov Disord 8:1–13
Huppke P, Brendel C, Kalscheuer V, Korenke GC, Marquardt I, Freisinger P, Christodoulou J, Hillebrand M, Pitelet G, Wilson C, Gruber-Sedlmayr U, Ullmann R, Haas S, Elpeleg O, Nurnberg G, Nurnberg P, Dad S, Moller LB, Kaler SG, Gartner J (2012) Mutations in SLC33A1 cause a lethal autosomal-recessive disorder with congenital cataracts, hearing loss, and low serum copper and ceruloplasmin. Am J Hum Genet 90:61–68
Jain S, Farias GG, Bonifacino JS (2015) Polarized sorting of the copper transporter ATP7B in neurons mediated by recognition of a dileucine signal by AP-1. Mol Biol Cell 26:218–228
Kahra D, Kovermann M, Wittung-Stafshede P (2016) The C-terminus of human copper importer Ctr1 acts as a binding site and transfers copper to Atox1. Biophys J 110:95–102
Kaler S, Batzios S, Tal G, DiStasio A, Peng Y, Charalambous C, Nicolaides P, Kamsteeg E-J, Korman S, Mandel H, Steinbach P, Yi L, Fair S, Heste M, Drousiotou A (2022) OP004: newly identified disorder of copper metabolism caused by variants in CTR1, a high-affinity copper transporter. Genet Med 24:S335–S336
Kluska A, Kulecka M, Litwin T, Dziezyc K, Balabas A, Piatkowska M, Paziewska A, Dabrowska M, Mikula M, Kaminska D, Wiernicka A, Socha P, Czlonkowska A, Ostrowski J (2019) Whole-exome sequencing identifies novel pathogenic variants across the ATP7B gene and some modifiers of Wilson’s disease phenotype. Liver Int: Official J Int Assoc Study Liver 39:177–186
Koboldt DC, Hickey SE, Chaudhari BP, Mihalic Mosher T, Bedrosian T, Crist E, Kaler SG, McBride K, White P, Wilson RK (2020) Early-onset Wilson disease caused by ATP7B exon skipping associated with intronic variant. Cold Spring Harb Mol Case Stud 6(3):a005306
Kumari N, Kumar A, Pal A, Thapa BR, Modi M, Prasad R (2019) In-silico analysis of novel p. (Gly14Ser) variant of ATOX1 gene: plausible role in modulating ATOX1-ATP7B interaction. Mol Biol Rep 46:3307–3313
Lebon S, Minai L, Chretien D, Corcos J, Serre V, Kadhom N, Steffann J, Pauchard JY, Munnich A, Bonnefont JP, Rotig A (2007) A novel mutation of the NDUFS7 gene leads to activation of a cryptic exon and impaired assembly of mitochondrial complex I in a patient with Leigh syndrome. Mol Genet Metab 92:104–108
Lee BH, Kim JH, Lee SY, Jin HY, Kim KJ, Lee JJ, Park JY, Kim GH, Choi JH, Kim KM, Yoo HW (2011) Distinct clinical courses according to presenting phenotypes and their correlations to ATP7B mutations in a large Wilson’s disease cohort. Liver Int 31:831–839
Liu WL, Li F, Liu L, Chen W, He ZX, Gu H, Ai R (2020) A novel gross deletion and breakpoint junction sequence analysis of ATP7B in a Chinese family with Wilson disease using nextgeneration sequencing and Sanger sequencing. Mol Med Rep 21:517–523
Locke JM, Hysenaj G, Wood AR, Weedon MN, Harries LW (2015) Targeted allelic expression profiling in human islets identifies cis-regulatory effects for multiple variants identified by type 2 diabetes genome-wide association studies. Diabetes 64:1484–1491
Loudianos G, Dessi V, Lovicu M, Angius A, Figus A, Lilliu F, De Virgiliis S, Nurchi AM, Deplano A, Moi P, Pirastu M, Cao A (1999) Molecular characterization of wilson disease in the Sardinian population–evidence of a founder effect. Hum Mutat 14:294–303
Magalhaes A, Burin MG, Souza CFM, de Bitencourt FH, Sebastiao FM, Silva TO, Vairo FPE, Schwartz IVD (2020) Transferrin isoelectric focusing for the investigation of congenital disorders of glycosylation: analysis of a ten-year experience in a Brazilian center. J Pediatr (rio j) 96:710–716
Mak CM, Lam CW (2008) Diagnosis of Wilson’s disease: a comprehensive review. Crit Rev Clin Lab Sci 45:263–290
Marchi G, Busti F, Lira Zidanes A, Castagna A, Girelli D (2019) Aceruloplasminemia: a severe neurodegenerative disorder deserving an early diagnosis. Front Neurosci 13:325
Margarit E, Bach V, Gomez D, Bruguera M, Jara P, Queralt R, Ballesta F (2005) Mutation analysis of Wilson disease in the Spanish population – identification of a prevalent substitution and eight novel mutations in the ATP7B gene. Clin Genet 68:61–68
Marques-da-Silva D, Dos Reis FV, Monticelli M, Janeiro P, Videira PA, Witters P, Jaeken J, Cassiman D (2017) Liver involvement in congenital disorders of glycosylation (CDG). A systematic review of the literature. J Inherit Metab Dis 40:195–207
Martinelli D, Dionisi-Vici C (2014) AP1S1 defect causing MEDNIK syndrome: a new adaptinopathy associated with defective copper metabolism. Ann N Y Acad Sci 1314:55–63
Maynard CJ, Cappai R, Volitakis I, Cherny RA, White AR, Beyreuther K, Masters CL, Bush AI, Li QX (2002) Overexpression of Alzheimer’s disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J Biol Chem 277:44670–44676
Medici V, LaSalle JM (2019) Genetics and epigenetic factors of Wilson disease. Ann Transl Med 7:S58
Miguel-Escalada I, Pasquali L, Ferrer J (2015) Transcriptional enhancers: functional insights and role in human disease. Curr Opin Genet Dev 33:71–76
Mirowska-Guzel D, Litwin T, Gromadzka G, Czlonkowski A, Czlonkowska A (2013) Influence of BDNF polymorphisms on Wilson’s disease susceptibility and clinical course. Metab Brain Dis 28:447–453
Mordaunt CE, Kieffer DA, Shibata NM, Czlonkowska A, Litwin T, Weiss KH, Zhu Y, Bowlus CL, Sarkar S, Cooper S, Wan YY, Ali MR, LaSalle JM, Medici V (2019) Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers. Epigenetics Chromatin 12:10
Mufti AR, Burstein E, Csomos RA, Graf PC, Wilkinson JC, Dick RD, Challa M, Son JK, Bratton SB, Su GL, Brewer GJ, Jakob U, Duckett CS (2006) XIAP Is a copper binding protein deregulated in Wilson’s disease and other copper toxicosis disorders. Mol Cell 21:775–785
Mukherjee S, Dutta S, Majumdar S, Biswas T, Jaiswal P, Sengupta M, Bhattacharya A, Gangopadhyay PK, Bavdekar A, Das SK, Ray K (2014) Genetic defects in Indian Wilson disease patients and genotype-phenotype correlation. Parkinsonism Relat Disord 20:75–81
Nemeth D, Arvai K, Horvath P, Kosa JP, Tobias B, Balla B, Folhoffer A, Krolopp A, Lakatos PA, Szalay F (2016) Clinical use of next-generation sequencing in the diagnosis of Wilson’s disease. Gastroenterol Res Pract 2016:4548039
Nicastro E, Ranucci G, Vajro P, Vegnente A, Iorio R (2010) Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology 52:1948–1956
O’Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer’s disease. Annu Rev Neurosci 34:185–204
Panichareon B, Taweechue K, Thongnoppakhun W, Aksornworanart M, Pithukpakorn M, Yenchitsomanus PT, Limwongse C, Limjindaporn T (2011) Six novel ATP7B mutations in Thai patients with Wilson disease. Eur J Med Genet 54:103–107
Parisi S, Polishchuk EV, Allocca S, Ciano M, Musto A, Gallo M, Perone L, Ranucci G, Iorio R, Polishchuk RS, Bonatti S (2018) Characterization of the most frequent ATP7B mutation causing Wilson disease in hepatocytes from patient induced pluripotent stem cells. Sci Rep 8:6247
Park S, Park JY, Kim GH, Choi JH, Kim KM, Kim JB, Yoo HW (2007) Identification of novel ATP7B gene mutations and their functional roles in Korean patients with Wilson disease. Hum Mutat 28:1108–1113
Polishchuk EV, Concilli M, Iacobacci S, Chesi G, Pastore N, Piccolo P, Paladino S, Baldantoni D, Van Sven ICD, Chan J, Chang CJ, Amoresano A, Pane F, Pucci P, Tarallo A, Parenti G, Brunetti-Pierri N, Settembre C, Ballabio A, Polishchuk RS (2014) Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis. Dev Cell 29:686–700
Poon KS, Tan KM, Koay ES (2016) Targeted next-generation sequencing of the ATP7B gene for molecular diagnosis of Wilson disease. Clin Biochem 49:166–171
Porubsky D, Ebert P, Audano PA, Vollger MR, Harvey WT, Marijon P, Ebler J, Munson KM, Sorensen M, Sulovari A, Haukness M, Ghareghani M, Human Genome Structural Varaition C, Lansdorp PM, Paten B, Devine SE, Sanders AD, Lee C, Chaisson MJP, Korbel JO, Eichler EE, Marschall T (2021) Fully phased human genome assembly without parental data using single-cell strand sequencing and long reads. Nat Biotechnol 39:302–308
Przybylkowski A, Gromadzka G, Wawer A, Grygorowicz T, Cybulska A, Czlonkowska A (2013) Intestinal expression of metal transporters in Wilson’s disease. Biometals 26:925–934
Przybylkowski A, Gromadzka G, Czlonkowska A (2014) Polymorphisms of metal transporter genes DMT1 and ATP7A in Wilson’s disease. J Trace Elem Med Biol 28:8–12
Quadri M, Kamate M, Sharma S, Olgiati S, Graafland J, Breedveld GJ, Kori I, Hattiholi V, Jain P, Aneja S, Kumar A, Gulati P, Goel M, Talukdar B, Bonifati V (2015) Manganese transport disorder: novel SLC30A10 mutations and early phenotypes. Mov Disord : Official J Mov Disord Soc 30:996–1001
Rodriguez-Quiroga SA, Rosales J, Arakaki T, Cordoba M, Gonzalez-Moron D, Medina N, Garretto NS, Kauffman MA (2015) Timely diagnosis of Wilson’s disease using whole exome sequencing. Parkinsonism Relat Disord 21:1375–1377
Roy S, Ganguly K, Pal P, Ghosh S, Das SK, Gangopadhyay PK, Bavdekar A, Ray K, Sengupta M, Ray J (2018) Influence of Apolipoprotein E polymorphism on susceptibility of Wilson disease. Ann Hum Genet 82:53–59
Roy S, McCann CJ, Ralle M, Ray K, Ray J, Lutsenko S, Jayakanthan S (2020) Analysis of Wilson disease mutations revealed that interactions between different ATP7B mutants modify their properties. Sci Rep 10:13487
Sanchez-Monteagudo A, Alvarez-Sauco M, Sastre I, Martinez-Torres I, Lupo V, Berenguer M, Espinos C (2020) Genetics of Wilson disease and Wilson-like phenotype in a clinical series from eastern Spain. Clin Genet 97:758–763
Schneider SA, Dusek P, Hardy J, Westenberger A, Jankovic J, Bhatia KP (2013) Genetics and pathophysiology of neurodegeneration with brain iron accumulation (NBIA). Curr Neuropharmacol 11:59–79
Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P, Sardiello M, Rubinsztein DC, Ballabio A (2011) TFEB links autophagy to lysosomal biogenesis. Science 332:1429–1433
Stamelou M, Tuschl K, Chong WK, Burroughs AK, Mills PB, Bhatia KP, Clayton PT (2012) Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder. Mov Disord 27:1317–1322
Stewart DJ, Short KK, Maniaci BN, Burkhead JL (2019) COMMD1 and PtdIns(4,5)P2 interaction maintain ATP7B copper transporter trafficking fidelity in HepG2 cells. J cell sci 6:33
Sticova E, Neroldova M, Kotalova R, Subhanova I, Jirsa M (2020) ABCB4 disease mimicking morbus Wilson: A potential diagnostic pitfall. Biomed Pap Med Fac Univ Palacky, Olomouc, Czechoslov 164:121–125
Summers KL, Dolgova NV, Gagnon KB, Sopasis GJ, James AK, Lai B, Sylvain NJ, Harris HH, Nichol HK, George GN, Pickering IJ (2020) PBT2 acts through a different mechanism of action than other 8-hydroxyquinolines: an X-ray fluorescence imaging study. Metallomics 12:1979–1994
Taly AB, Meenakshi-Sundaram S, Sinha S, Swamy HS, Arunodaya GR (2007) Wilson disease: description of 282 patients evaluated over 3 decades. Medicine 86:112–121
Tan X, Guan H, Yang Y, Luo S, Hou L, Chen H, Li J (2020) Cu(II) disrupts autophagy-mediated lysosomal degradation of oligomeric Abeta in microglia via mTOR-TFEB pathway. Toxicol Appl Pharmacol 401:115090
Todorov T, Balakrishnan P, Savov A, Socha P, Schmidt HH (2016) Intragenic deletions in ATP7B as an unusual molecular genetics mechanism of Wilson’s disease pathogenesis. PLoS ONE 11:e0168372
Tumer Z (2013) An overview and update of ATP7A mutations leading to Menkes disease and occipital horn syndrome. Hum Mutat 34:417–429
Tuschl K, Meyer E, Valdivia LE, Zhao N, Dadswell C, Abdul-Sada A, Hung CY, Simpson MA, Chong WK, Jacques TS, Woltjer RL, Eaton S, Gregory A, Sanford L, Kara E, Houlden H, Cuno SM, Prokisch H, Valletta L, Tiranti V, Younis R, Maher ER, Spencer J, Straatman-Iwanowska A, Gissen P, Selim LA, Pintos-Morell G, Coroleu-Lletget W, Mohammad SS, Yoganathan S, Dale RC, Thomas M, Rihel J, Bodamer OA, Enns CA, Hayflick SJ, Clayton PT, Mills PB, Kurian MA, Wilson SW (2016) Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia. Nat Commun 7:11601
Vaz-Drago R, Custodio N, Carmo-Fonseca M (2017) Deep intronic mutations and human disease. Hum Genet 136:1093–1111
Vidyadhara DJ, Lee JE, Chandra SS (2019) Role of the endolysosomal system in Parkinson’s disease. J Neurochem 150:487–506
Wan L, Tsai CH, Hsu CM, Huang CC, Yang CC, Liao CC, Wu CC, Hsu YA, Lee CC, Liu SC, Lin WD, Tsai FJ (2010) Mutation analysis and characterization of alternative splice variants of the Wilson disease gene ATP7B. Hepatology 52:1662–1670
Wang T, Weinman SA (2004) Involvement of chloride channels in hepatic copper metabolism: ClC-4 promotes copper incorporation into ceruloplasmin. Gastroenterology 126:1157–1166
Wang LH, Huang YQ, Shang X, Su QX, Xiong F, Yu QY, Lin HP, Wei ZS, Hong MF, Xu XM (2011) Mutation analysis of 73 southern Chinese Wilson’s disease patients: identification of 10 novel mutations and its clinical correlation. J Hum Genet 56:660–665
Wei Z, Huang Y, Liu A, Diao S, Yu Q, Peng Z, Hong M (2014) Mutational characterization of ATP7B gene in 103 Wilson’s disease patients from Southern China: identification of three novel mutations. NeuroReport 25:1075–1080
Weiss KH, Runz H, Noe B, Gotthardt DN, Merle U, Ferenci P, Stremmel W, Fullekrug J (2010) Genetic analysis of BIRC4/XIAP as a putative modifier gene of Wilson disease. J Inherit Metab Dis 33(Suppl 3):S233-240
White AR, Reyes R, Mercer JF, Camakaris J, Zheng H, Bush AI, Multhaup G, Beyreuther K, Masters CL, Cappai R (1999) Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res 842:439–444
Woimant F, Djebrani-Oussedik N, Poujois A (2019) New tools for Wilson’s disease diagnosis: exchangeable copper fraction. Ann Transl Med 7:S70
Woimant F, Poujois A, Bloch A, Jordi T, Laplanche JL, Morel H, Collet C (2020) A novel deep intronic variant in ATP7B in five unrelated families affected by Wilson disease. Mol Genet Genomic Med 8:e1428
Yang CS, Liang XL, Li JY, Yan ZW, Huang F (2005) Effect of the mutation of promoter region in Wilson disease ATP7B gene on the expression of reporter gene. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22:566–568
Yasmeen S, Lund K, De Paepe A, De Bie S, Heiberg A, Silva J, Martins M, Skjorringe T, Moller LB (2014) Occipital horn syndrome and classical Menkes Syndrome caused by deep intronic mutations, leading to the activation of ATP7A pseudo-exon. Eur J Hum Genet 22:517–521
Yu CH, Yang N, Bothe J, Tonelli M, Nokhrin S, Dolgova NV, Braiterman L, Lutsenko S, Dmitriev OY (2017) The metal chaperone Atox1 regulates the activity of the human copper transporter ATP7B by modulating domain dynamics. J Biol Chem 292:18169–18177
Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ (2001) A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 28:345–349
Zhou XX, Li XH, Chen DB, Wu C, Feng L, Qin HL, Pu XY, Liang XL (2019) Injury factors and pathological features of toxic milk mice during different disease stages. Brain Behav 9:e01459
Acknowledgements
We are thankful to the Wilson’s disease patients and their family members. SR was supported by UGC-JRF fellowship from UGC, Govt. of India and SG was supported by a fellowship from DST-SERB, Govt. of India.
Funding
This study received no funding support.
Author information
Authors and Affiliations
Contributions
SR provided pipeline for selecting cis-regulatory element from ENCODE database and contributed to analysis of the result and drafted the manuscript; SG performed in silico analysis following the pipeline for selecting cis-regulatory element from ENCODE database; JR contributed to overall supervision of the project and reviewing of the manuscript; KR contributed to conceptualization of the study critical review of the manuscript and other intellectual inputs; MSG contributed to conceptualization of the study, overall supervision of the project, and reviewing of the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interest.
Ethical approval
This study did not include any human or animal subjects and/or patients’ clinical information.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Roy, S., Ghosh, S., Ray, J. et al. Missing heritability of Wilson disease: a search for the uncharacterized mutations. Mamm Genome 34, 1–11 (2023). https://doi.org/10.1007/s00335-022-09971-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-022-09971-y